AVMA news
FSIS veterinary position created to improve retention
The U.S. Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS) has created a higher-graded position for veterinarians in…
AVMA news
HHS, senators request DEA reschedule marijuana
Legislators are seeking to remove marijuana from the Controlled Substances Act (CSA) after the U.S. Department of Health and Human Services (HHS)…
AVMA news
USDA continues monitoring for African swine fever as it persists globally
African swine fever (ASF) has not entered the U.S. thanks to continuing efforts to prevent this deadly swine disease from reaching the country’s…
AVMA news
FDA CVM lays out innovation plan for new animal, veterinary products
Leaders with the Food and Drug Administration’s Center for Veterinary Medicine recently outlined the agency’s plan to support the development of safe…
AVMA news
Facing shortage, FDA CVM allows temporary imports of non-FDA approved drug for cattle
A national shortage of an important cattle reproduction drug has prompted the Food and Drug Administration to allow a similar but unapproved product…
AVMA news
FDA warns manufacturers, distributors of unapproved antimicrobials for animals
The U.S. Food and Drug Administration (FDA) on December 14 announced it has issued nine warning letters to manufacturers and distributors of…
AVMA news
New drug calms cats during transportation, veterinary visits
The Food and Drug Administration (FDA) this November approved Bonqat, a nerve pain medication for cats to alleviate acute anxiety and fear associated…
blog
Here’s one promising approach to address rural veterinary shortages
There are veterinarians who want to work in rural areas of America but are unable to do so—for financial reasons. The great news is that legislation…
AVMA news
FDA releases updated plan for antimicrobial stewardship in veterinary settings
The U.S. Food and Drug Administration’s Center for Veterinary Medicine on October 1 launched the latest phases of its ongoing plan to promote…
AVMA news
Artificial intelligence in veterinary medicine: What are the ethical and legal implications?
AVMA Axon recently debuted the webinar "Do No Harm: Ethical and Legal Implications of A.I." by Dr. Dr. Eli Cohen, a clinical professor of diagnostic…
AVMA news
A research facility ahead of its time
The state-of-the-art National Bio and Agro-Defense Facility, based in the nation’s heartland, is arguably the most advanced animal agriculture…
AVMA news
Lawmakers form first-ever Senate Veterinary Medicine Caucus
U.S. Senators Cindy Hyde-Smith and Amy Klobuchar announced August 3 the creation of the inaugural Senate Veterinary Medicine Caucus. It was created to…
AVMA news
Advances in animal genome editing continue apace
The Food and Drug Administration (FDA) recently green lit for human consumption five genetically modified pigs at Washington State University.…
AVMA news
Canine osteoarthritis drug, Lyme disease bacteria vaccine receive approvals
Two recent drug approvals mean a novel treatment for the control of canine osteoarthritis (OA) pain and an oral vaccine against the wildlife spread of…
AVMA news
USDA starts highly pathogenic avian influenza vaccine trials
In April, the U.S. Department of Agriculture (USDA) began testing the efficacy of four vaccines against highly pathogenic avian influenza (HPAI).…
AVMA news
EPA, FDA weigh oversight overhaul for animal parasite products
Two federal agencies are considering transferring oversight of some 600 products from the Environmental Protection Agency (EPA) to the Food and Drug…
AVMA news
AVMA testifies in support of improving new animal drug review efficiency
AVMA President Lori Teller appeared before a House subcommittee to urge reauthorization of legislation supporting approval of new and generic animal…
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
AVMA news
New law clarifies alternatives to animal testing for safety, efficacy of drugs
The recently passed FDA Modernization Act 2.0 authorizes the use of certain alternatives to animal testing, including cell-based assays and computer…
AVMA news
Remaining medically important antimicrobials transitioning to prescription status
The Food and Drug Administration is reminding stakeholders that certain over-the-counter antimicrobial products for animals are transitioning to…
blog
Congressional offices consider making xylazine a controlled substance
With illicit xylazine increasingly showing up in street drugs that pose grave risks to human users, government policymakers are discussing making it a…
AVMA news
Honeybee vaccine receives conditional license from USDA
The U.S. Department of Agriculture has granted a conditional license for a vaccine to protect honeybees against American foulbrood. The only…
AVMA news
Sales, distribution of medically important antimicrobials remain down for food animals
Annual sales and distribution by volume of medically important antimicrobials for food-producing animals remain down since the substantial decrease in…
AVMA news
From Congress to the courtroom, AVMA advocates for veterinarians
The AVMA’s advocacy on behalf of its members covers practically every aspect of veterinary medicine and takes place in the federal government,…
AVMA news
FDA warns that topical drug for humans can be deadly to pets
As of September, the Food and Drug Administration had received 14 reports involving 20 dogs that had been accidentally exposed to topical…